Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Intraperitoneal oxidative stress in rabbits with papillomavirus-associated head and neck cancer induces tumoricidal immune response that is adoptively transferable.

Rossmann A, Mandic R, Heinis J, Höffken H, Küssner O, Kinscherf R, Weihe E, Bette M.

Clin Cancer Res. 2014 Aug 15;20(16):4289-301. doi: 10.1158/1078-0432.CCR-14-0677. Epub 2014 Jun 18.


Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas.

Schulz S, Häussler U, Mandic R, Heverhagen JT, Neubauer A, Dünne AA, Werner JA, Weihe E, Bette M.

Int J Cancer. 2008 May 15;122(10):2360-7. doi: 10.1002/ijc.23382.


Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.

Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.

Clin Cancer Res. 2002 Oct;8(10):3137-45.


Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.

Junker N, Andersen MH, Wenandy L, Dombernowsky SL, Kiss K, Sørensen CH, Therkildsen MH, Von Buchwald C, Andersen E, Straten PT, Svane IM.

Cytotherapy. 2011 Aug;13(7):822-34. doi: 10.3109/14653249.2011.563291. Epub 2011 Mar 24.


Intraperitoneal oxidative stress as an oncolytic immunomodulator?

Bette M, Mandic R.

Oncoimmunology. 2014 Dec 13;3(9):e955347. eCollection 2014 Dec 13.


Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.

Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.

Clin Cancer Res. 2000 Jun;6(6):2268-78.


PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.

Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A, Besnier N, Gey A, Rotem-Yehudar R, Pere H, Tran T, Guerin CL, Chauvat A, Dransart E, Alanio C, Albert S, Barry B, Sandoval F, Quintin-Colonna F, Bruneval P, Fridman WH, Lemoine FM, Oudard S, Johannes L, Olive D, Brasnu D, Tartour E.

Cancer Res. 2013 Jan 1;73(1):128-38. doi: 10.1158/0008-5472.CAN-12-2606. Epub 2012 Nov 7.


Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.

Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL.

Clin Cancer Res. 2004 Oct 15;10(20):6929-37.


Generation of therapeutic T cells from draining lymph nodes in a murine model of head and neck squamous cell carcinoma.

Sadeghi N, Black MJ, Hier MP, Shenouda G, Karp SE.

Arch Otolaryngol Head Neck Surg. 1997 Jan;123(1):25-30.


A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.

Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, Whiteside TL.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54.


Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.

Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E.

Clin Cancer Res. 2006 Jan 15;12(2):465-72.


Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.

Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL.

Cancer Res. 2005 Dec 1;65(23):11146-55.


Lymphogenic metastatic spread of auricular VX2 carcinoma in New Zealand white rabbits.

Dünne AA, Mandic R, Ramaswamy A, Plehn S, Schulz S, Lippert BM, Moll R, Werner JA.

Anticancer Res. 2002 Nov-Dec;22(6A):3273-9.


Adenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.

Mulders P, Tso CL, Pang S, Kaboo R, McBride WH, Hinkel A, Gitlitz B, Dannull J, Figlin R, Belldegrun A.

J Immunother. 1998 May;21(3):170-80.


Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma.

Li F, Shanmugam MK, Chen L, Chatterjee S, Basha J, Kumar AP, Kundu TK, Sethi G.

Cancer Prev Res (Phila). 2013 Aug;6(8):843-54. doi: 10.1158/1940-6207.CAPR-13-0070. Epub 2013 Jun 26.


CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.

Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, Cho HT, Shin DM, Goodman MM, Chen ZG, Shim H.

Cancer Res. 2007 Aug 1;67(15):7518-24.


Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.

Uppaluri R, Dunn GP, Lewis JS Jr.

Cancer Immun. 2008 Dec 4;8:16. Review.

Supplemental Content

Support Center